Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 2 6Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 1Glioblastoma 1

Interventions

Temozolomide 39Radiotherapy 18Lomustine 12Bevacizumab 11Carmustine 8Radiation 7Procarbazine 4Magnetic Resonance Spectroscopy 4Surgical Procedures, Operative 3pembrolizumab 2depatuxizumab mafodotin 2Tf-CRM107 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Drug Therapy 2Dihematoporphyrin Ether 2DNA Methylation 2Carboplatin 2ABT-414 2trans-sodium crocetinate 1tofacitinib 1sargramostim 1rindopepimut 1niraparib 1marizomib 1enzastaurin 1edotecarin 1contrast agent BR1 1cediranib 1carmustine, poliferprosan 20 drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Glioblastoma × O(6)-benzylguanine × Clear all
NCT00017147 2013-01-30

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

SWOG Cancer Research Network

Phase 3 Completed
183 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡